
KalVista Pharma (KALV) Earnings Dates & Reports
KalVista Pharma (KALV) Most Recent Earnings
Report DateMar 12, 2025
Period EndingQ3 2025
Est. EPS-$0.88
Actual EPS-$0.92
EarningsMiss
KalVista Pharma (KALV) Earnings
View the latest KalVista Pharma (KALV) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in KalVista Pharma (KALV)
Order type
Buy in
Order amount
Est. shares
0 shares
KalVista Pharma (KALV) Earnings per Share (EPS) History
Signup for full accessBrowse free
KalVista Pharma (KALV) Latest Earnings
The value each KALV share was expected to gain vs. the value each share gained.
KalVista Pharma (KALV) reported its most recent earnings on Mar 12, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.92. This exceeded analysts' expectations of -$0.88 by 4.55%, marking a Miss.
For comparison, KalVista Pharma reported EPS of -$0.84 in the same quarter last year.
The company is expected to announce its next earnings report on 07/10/2025, with analysts projecting an EPS of -$0.92.
KalVista Pharma (KALV) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q4 2025Jul 10, 2025 | -$0.92 | Next earnings call Jul. 10, 2025 | ||
Q3 2025Mar 12, 2025 | -$0.88 | -$0.92 | +4.55% | |
Q2 2025Dec 5, 2024 | -$0.91 | -$0.91 | 0.00% | |
Q1 2025Sep 5, 2024 | -$0.86 | -$0.87 | +1.16% | |
Q4 2024Jul 11, 2024 | -$0.73 | -$1.02 | +39.73% | |
KalVista Pharma (KALV) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the KalVista Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Mar 12, 2025 | — | — | — |
Dec 5, 2024 | — | — | — |
Sep 5, 2024 | — | — | — |
Jul 11, 2024 | — | — | — |
KalVista Pharma (KALV) Earnings FAQs
KalVista Pharma (KALV) last reported earnings on Mar 12, 2025 for Q3 2025, posting an EPS of -$0.92, which Miss the estimate of -$0.88 by 4.55%.
For Q3 2025, KalVista Pharma (KALV) reported an EPS of -$0.92, missing analysts' estimate of -$0.88 by 4.55%.
For Q3 2025, KalVista Pharma (KALV) Miss expectations with an actual EPS of -$0.92 vs. an estimated EPS of -$0.88.
Following the last earnings report on Mar 12, 2025, KalVista Pharma (KALV)'s stock price moved — from — to —.
The next KalVista Pharma (KALV) earnings call is scheduled for Jul. 10, 2025, where executives will discuss financial results and outlook.